Report
Nicholas Cortellucci, CFA

BQE: Q4 Financials Preview

What you need to know:
• BQE will be reporting Q4 & 2023 financial results in ~2 weeks, we are expecting proportional revenue of $4.2M, gross margin of 45%, and adj. EBITDA of $0.6M (14% margin).
• Metals prices have been rising steadily over the last month with copper up 9%. BQE’s China JV has leverage to the copper price as it sells recovered metals.
• BQE remains cheap at 10.0x/8.6x 2024E/2025E EBITDA.

BQE Water (BQE:TSXV, BTQNF:OTC) will be reporting Q4 and 2023 financial results around April 25th. We are expecting another strong quarter from BQE, albeit Q4 being a seasonally weak quarter. An overview of our estimates can be found below. BQE stock is up 47% since our initiation report last month (read here), yet we are still highly bullish in our thesis and will reassess our target price on the back of the financial results. We are maintaining our BUY rating and $55.00/share target price on BQE Water.

Q4 & 2023 Financials Preview
For Q4, we are expecting:
• Proportional revenue of $4.2M (-2% YoY) comprised of reported revenue at $2.8M and share of JV revenue at $1.4M
• Gross margin of 45% compared to 41% in Q4/22 (note that this is reported as operating margin before depreciation)
• Adjusted EBITDA of $0.6M (14% margin) compared to ($0.1M) in Q4/22
• Net income of $0.4M or $0.29/share compared to ($0.2M) or ($0.19/share) in Q4/22

For 2023, we are expecting:
• Proportional revenue of $21.5M (+14% YoY) comprised of reported revenue at $15.9M and share of JV revenue at $5.6M
• Gross margin of 48% compared to 42% in 2022
• Adjusted EBITDA of $4.7M (22% margin) compared to $3.1M (16% margin) in 2022
• Net income of $2.8M or $2.22/share vs. $1.2M or $0.93/share in 2022
Underlying
BQE WATER INC.

BQE Water is engaged in the acquisition and development of processes to treat metal-laden, sulphate-rich waste water streams for acid neutralization and metal recovery. The principal operations of Co. are to build process plants and earn revenues from recovered metals, treatment fees, plant sales and process licenses.

Provider
Atrium Research Corporation
Atrium Research Corporation

Atrium Research provides institutional quality issuer paid research on North American public equities using deep fundamental analysis. Our research reports are disseminated through Bloomberg, FactSet, Capital IQ, Reuters and many more, as well as through our social media and email distribution lists. 

Analysts
Nicholas Cortellucci, CFA

Other Reports on these Companies
Other Reports from Atrium Research Corporation

ResearchPool Subscriptions

Get the most out of your insights

Get in touch